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Abstract
We have adapted a solution hybrid selection protocol to enrich pathogen DNA in clinical samples dominated by
human genetic material. Using mock mixtures of human and Plasmodium falciparum malaria parasite DNA as well as
clinical samples from infected patients, we demonstrate an average of approximately 40-fold enrichment of parasite
DNA after hybrid selection. This approach will enable efficient genome sequencing of pathogens from clinical samples,
as well as sequencing of endosymbiotic organisms such as Wolbachia that live inside diverse metazoan phyla.
Background
The falling cost of DNA sequencing means that sample
quality, rather than expense, is now the blocking issue
for many infectious disease genome sequencing projects.
Pathogen genomes are generally very small relative to
that of their human host, and are typically haploid in
nature. Therefore, even a modest number of nucleated
human cells present in infectious disease samples may
result in the pathogen DNA representation being dwar-
fed relative to the host human DNA. This difference in
representation poses a significant challenge to achieving
adequate sequence coverage of the pathogen genome in
a cost-effective manner. Separation of host and patho-
gen cells prior to DNA extraction can be difficult or
inconvenient, particularly in field settings common to
clinics in developing countries.
This barrier to the efficient sequencing of pathogen
genomes comes at a time when the potential motiva-
tions and rewards for large-scale sequencing of patho-
gens are becoming increasingly clear. Examples abound
to demonstrate how whole-genome analyses of pathogen
population structure from large numbers of isolates can
help to identify the source of disease outbreaks or hid-
den subpopulations. Whole genome sequencing of 35
Salmonella enterica samples was recently performed by
the United States Food and Drug Administration in
order to identify the source of a foodborne illness out-
break that affected approximately 300 individuals in
2009 and 2010 [1]. Whole genome sequencing of 20 iso-
lates of pathogenic Coccidiodies spp. fungi identified
gene flow in select genomic regions between the
recently diverged Coccidiodies immitis and Coccidiodies
posadasii [2]. Whole genome sequencing and compara-
tive SNP analysis of unculturable Mycobacterium leprae
isolates was utilized to demonstrate that a third of
leprosy infections in the United States derive from
armadillos [3]. So-called ‘third generation’ sequencing
was successfully employed to identify the origin of the
recent Haitian cholera outbreak strain via de novo
sequencing of 5 isolates and comparison of those
sequences to 23 previously sequenced isolates of Vibrio
cholera [4]. In addition, the increasing use of genome-
wide association studies to determine the genetic basis
of important infectious disease phenotypes, such as drug
resistance in malaria parasites [5,6], will require sequen-
cing or genotyping hundreds to thousands of pathogen
isolates, making a shortage of quality specimens an
acute problem. All of these studies could have been per-
formed more expediently if a culturing step were not
required to eliminate DNA derived from the host or
environment.
Existing methods for dealing with DNA contamination
in infectious disease samples typically require significant
time, money, and/or special handling of samples at the
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model case, malaria parasite samples in blood may be
adapted to in vitro culture and sustained in a pure med-
ium of DNA-free human red blood cells. The adaptation
process, however, can take more than 6 weeks, requires
considerable expertise and expense [7], and may poten-
tially select for culturable variants. To remedy this,
DNA-containing white blood cells may be depleted
directly from malaria patient blood samples prior to cell
lysis via differential density centrifugation or column fil-
tration [8-10]. While depletion methodologies may
reduce white cell abundance to levels useful for bio-
chemical assays, the 100-fold disparity in genome size
between human and malaria means that an even modest
number of host cells can compromise a sample for gen-
ome sequencing. In addition, white blood cell depletion
currently requires a significant volume of blood to be
drawn from patients (approximately 5 ml), and the
blood must then be stored at minus 70°C in a special
medium to preserve cellular integrity. This could pre-
clude sample collection for genome sequencing from
many clinical trials due to protocol limitations or lack of
equipment in the field. Furthermore, pathogens that
infect or closely associate with nucleated host cells, such
as Plasmodium vivax, Trypanosoma cruzi,o rChlamydia
trachomatis, are not amenable to purification by white
cell depletion. Endosymbionts such as Wolbachia, which
influence host fertility and other traits in filarial worms,
insect disease vectors, and diverse other taxa, may only
be cultured in an intracellular system [11], precluding
easy isolation of their genomic DNA for sequencing
except by elaborate methods [12].
To address this problem we have adapted a solution
hybrid selection approach originally developed for the pur-
ification of resequencing targets in the human genome
[13]. In brief, biotinylated RNA probes complementary to
the pathogen genome (’baits’) are hybridized to pathogen
DNA in solution and pulled down with magnetic strepta-
vidin-coated beads. Host DNA is washed away and the
captured pathogen DNA may then be eluted and amplified
for sequencing or genotyping. We experimented with two
approaches to bait design: synthetic 140-bp oligos target-
ing specific regions of the P. falciparum 3D7 reference
genome assembly and ‘whole genome baits’ (WGBs) gen-
erated from pure P. falciparum DNA. Using this protocol,
we achieved significant enrichment of P. falciparum DNA,
to a level that allowed us to conduct whole genome
sequencing on samples that otherwise would have been
prohibitively expensive to sequence.
Results and discussion
Hybrid selection on a mock clinical malaria sample
We performed hybrid selection with both classes of bait
on a mock clinical sample consisting of 99% human
DNA and 1% Plasmodium DNA by mass, which falls
within the range of DNA ratios found in many malaria
clinical samples (Table 1). Hybridization and washing
steps (see Materials and methods) were carried out
under standard high stringency conditions to reduce
capture of host DNA. The hybrid selection protocol
requires a minimum of 2 μgo fi n p u tD N A( c o m b i n e d
host and pathogen), a quantity that may not be available
from many types of field samples. Therefore, we also
performed hybrid selection with both bait classes on 2
μg of whole genome amplified DNA generated from 10
ng of the mock clinical sample. Quantitative PCR
(qPCR) analysis indicated that whole genome amplifica-
tion (WGA) does not significantly alter the fraction of
malaria DNA present in the sample (post-WGA percen-
tage P. falciparum DNA = 1.1 ± 0.1).
Sequencing of the hybrid-selected samples revealed a
significant increase in representation of Plasmodium
DNA in every case. The synthetic baits respectively
yielded an average of 41-fold and 44-fold parasite DNA
enrichment for unamplified and WGA simulated clinical
samples in genomic regions targeted by the baits, as
measured by qPCR. Whole genome baits yielded para-
site genome-wide average enrichment levels of 37-fold
and 40-fold for the unamplified and WGA input sam-
ples, respectively.
Illumina sequencing coverage in the WGB hybrid-
selected samples is correlated with GC content, mirror-
ing what is observed in sequencing data from pure P.
falciparum DNA (Figure 1a). With a genome-wide A/T
composition of 81% [14], achieving uniform sequencing
coverage of the P. falciparum genome is challenging
even under ideal circumstances. Despite this challenge,
we observed no reduction in coverage uniformity as a
result of the hybrid selection process. WGA did not
compromise mean genome-wide sequencing coverage
relative to unamplified input DNA (67.5 × versus 67.1 ×
for a single Illumina GAIIx lane, respectively). Sequen-
cing coverage of the samples hybrid selected using syn-
thetic 140-bp baits was tightly localized to the genomic
regions to which baits were designed (Figure 1b). Cover-
age levels in baited regions were significantly higher
than the levels observed from comparable sequencing of
pure P. falciparum DNA (mean coverage = 143.8 × and
92 ×, respectively; Wilcoxon rank sum test, W = 6.7E12,
P < 2.2e-16). This indicates that hybrid selection with
s y n t h e t i cb a i t sm a yb eu s e f u ln o to n l yf o rr e d u c i n go f f -
target coverage in the host genome, but also for strategi-
cally augmenting coverage levels in regions of pathogen
genomes where heightened sequence coverage could be
informative, such as highly polymorphic antigenic
regions subject to host immune pressure.
Though effective sequencing coverage levels are
reduced in the hybrid-selected mock clinical samples
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plete elimination of human DNA, this reduction is small
compared to the 100-fold reduction in coverage
expected without hybrid selection. Genome-wide cover-
age is depicted in Figure 2a, which illustrates that the
extent of the genome covered to various thresholds is
highly similar for the pure P. falciparum and hybrid-
selected mock clinical samples, and significantly higher
than simulated coverage levels we would have predicted
to have observed from sequencing an un-purified ver-
sion of the sample. Genome-wide coverage levels as a
function of the local %GC (the percentage of nucleotides
i nt h eg e n o m et h a ta r eGo rC ;% G + C )a r ep l o t t e di n
Figure 2b for the WGB experiments. The relationship
between %GC and coverage observed in whole genome
shotgun sequencing data is decreased by hybrid selec-
tion due to reduced coverage in rare high %GC genomic
regions (Spearman’s rs for %GC versus coverage of pure
malaria DNA, 0.86; versus WGB hybrid-selected DNA,
0.59; versus WGA + WGB hybrid-selected DNA, 0.64).
The vertical line in Figure 2b represents the average %
GC of exonic sequence (23%). Assuming a minimum
threshold of 10-fold sequencing coverage is required for
accurate SNP calling, 99.2% of exonic bases exhibited
this coverage or greater in reads generated from the
pure P. falciparum DNA sample. The unamplified and
amplified hybrid-selected samples achieved at least 10-
fold coverage for 98.3% and 98.0% of exonic bases,
respectively. Given that previous pathogen population
genomic analyses of outbreaks or population structure
have been SNP-based [1,2,4], this indicates that sequen-
cing data generated from hybrid-selected clinical sam-
ples could be as useful as data generated from pure
pathogen DNA samples for downstream analyses.
Further comparison of sequencing coverage between
hybrid-selected and pure P. falciparum DNA indicates
that local %GC and polymorphism rate do not signifi-
cantly influence sequencing coverage in a hybrid-
selected sample (Additional file 1).
We attempted to optimize our hybrid selection proto-
col by exploring two different hybridization temperatures
(60°C versus 65°C) and four different 10-minute wash
stringencies (0.1 × SSC, 0.25 × SSC,0.5 × SSC, and 0.75 ×
SSC). Eight mock clinical samples were hybridized with
WGB and washed under all combinations of the above
conditions. Enrichment was measured by qPCR and
sequencing (one indexed Illumina GAIIx lane). We
observed the best enrichment under the standard high
stringency conditions used for all previously reported
experiments (hybridization at 65°C and high stringency
wash (0.1 × SSC). Results are presented in Table 2.
In summary, both bait strategies performed effectively
and now offer investigators a method to sequence either
targeted regions or complete genomes of pathogens in
clinical samples dominated by host DNA. Pairing this
hybrid selection protocol with WGA further expands
the range of clinical samples now eligible for efficient
pathogen genome sequencing. For example, for Plasmo-
dium it should now be possible to sequence the parasite
genome directly from dried blood spots on filter paper,
an easily collectable and storable sample format.
Hybrid selection on authentic clinical samples
To test this application, we performed WGA and hybrid
selection on DNA extracted from a clinical P. falci-
parum sample (Th231.08) collected on filter paper in
Thies, Senegal in 2008 and stored at room temperature
for over a year. By qPCR we estimated the Plasmodium
Table 1 Quantitative PCR enrichment measurements from 12 clinical samples
Percentage Parasite [DNA] (pg/μl)
Sample parasite DNA WGA Pre-hybrid selection
a Post-hybrid selection
a Fold enrichment
Th231.08 (round 1) 0.11 Yes 1.8 (0.6) 71.1 (5.6) 39.7
Th231.08 (round 2) 7.7 No 71.1 (5.6) 349.1 (74.9) 4.9
Th145.08 20 No 198.4 (17.4) 477.6 (66.7) 2.4
Th032.09 12 No 114.7 (2.9) 372.6 (59.3) 3.2
Th029.09 3 No 33.6 (0.8) 317.3 (54.7) 9.4
Th093.09 2.8 No 28.5 (1.5) 365.6 (53.4) 12.8
Th090.08 2.3 No 37.7 (1.1) 300.4 (46.9) 8.0
Th139.08 2.1 No 23.6 (0.6) 346.2 (50.7) 14.7
Th197.08 1.1 No 14.6 (0.0) 222.7 (36.1) 15.3
Th140.08 0.99 No 9.6 (0.1) 251.5 (37.4) 26.2
Th190.08 0.64 No 5.1 (0.2) 218.7 (34.0) 43.2
Th238.08 0.53 No 6.7 (0.2) 273.4 (38.1) 41.0
Th127.09 1.6 No 26.8 (0.4) 368.5 (57.1) 13.7
Th175.08 48 Yes 275.8 (7.2) 556.9 (79.4) 2.0
aNumbers in parentheses represent standard deviations. WGA, whole genome amplification.
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Figure 1 Sequencing coverage plots from a randomly chosen region of P. falciparum chromosome 1.( a) Unamplified (green) and WGA
(purple) WGBs compared to pure P. falciparum (gray). (b) Unamplified (green) and WGA (purple) synthetic bait read coverage compared to pure
P. falciparum (gray). Red bars indicate bait locations. (c) Local %GC (the percentage of nucleotides in the genome that are G or C; in 140-bp
windows). Green bars indicate exons. Chr, chromosome.
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0.11% of the total DNA by mass. Following WGA and
hybrid selection, Plasmodium DNA represented 7.7% of
total DNA present, an approximately 70-fold increase in
parasite DNA representation. Illumina HiSeq sequencing
data confirmed that at least 5.9% of mappable reads in
the hybrid-selected sample corresponded to Plasmodium.
The fraction of human reads after hybrid selection
remained high due to the extreme initial ratio of host:
parasite DNA, but the enrichment factor in this case was
sufficient to rescue the feasibility of sequencing this sam-
ple. We evaluated the accuracy and utility of the data by
calling SNPs against the P. falciparum reference assem-
bly. We identified a total of 26,366 SNPs relative to the P.
falciparum reference assembly (more than one per kilo-
base), close to the number of SNPs identified (33,094 to
41,123) from 11 other culture-adapted Senegalese para-
site lines sequenced without hybrid selection. Further
SNPs could likely be discovered by further augmenting
coverage. While the depth of coverage we obtained from
this experiment would not be sufficient for de novo gen-
ome assembly, SNP calling against a reference assembly
is the end-stage analysis for most Illumina data (for
example, [1-4]) and therefore a good indication of a data-
set’s potential utility. Principal components analysis of
SNP genotypes confirms the similar genomic profile of
the hybrid-selected and non-hybrid-selected Senegalese
strains, as well as hybrid-selected and non-hybrid-
selected 3D7 reference strain datasets generated from
sequencing the mock clinical samples (Figure 3). Despite
the use of WGBs generated from the 3D7 reference gen-
ome, the DNA captured from the Senegal isolate has the
SNP profile of Senegal DNA, rather than 3D7 DNA, sug-
gesting that polymorphisms do not strongly bias enrich-
ment. In addition, the highly polymorphic regions of the
isolate did not suffer a relative drop in sequencing cover-
age after hybrid selection. Selection of a panel of 12 other
clinical malaria samples from Senegal yielded an average
of 35-fold enrichment, as measured by qPCR (Table 1),
with enrichment amount inversely proportional to the
initial fraction of parasite DNA in the samples.
We conducted a second round of hybrid selection on
the Th231.08 clinical sample to determine whether the
Plasmodium DNA titer in the sample could be boosted
above approximately 7%. The second round of hybrid
selection was carried out under identical hybridization
and wash conditions. qPCR analysis indicates this yielded
a sample in which 47.5% of the genetic material was Plas-
modium by mass (a 6.7-fold enrichment). This lower fold
enrichment is consistent with our previous observation
that fold enrichment is inversely proportional to initial
parasite DNA titer, but in this case an additional round
of hybrid selection yields a sample even more amenable
to cost-efficient and deep sequencing.
Although sequencing has become considerably less
expensive in recent years, it remains financially impractical
Table 2 Quantitative PCR enrichment measurements
Hybrid temperature Stringency Wash Pre-hybrid selection
[DNA] (pg/μl)
Post-hybrid selection
[DNA] (pg/μl)
Fold enrichment
65°C High 0.10 × SSC 10.0 342.9 34.3
Med/high 0.25 × SSC 10.0 258.2 25.8
Med/low 0.50 × SSC 10.0 227.9 22.8
Low 0.75 × SSC 10.0 181.4 18.1
60°C High 0.10 × SSC 10.0 288.6 28.9
Med/high 0.25 × SSC 10.0 232.9 23.3
Med/low 0.50 × SSC 10.0 203.5 20.4
Low 0.75 × SSC 10.0 196.3 19.6
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Figure 3 Principal component analysis plot based on SNP calls
produced from hybrid-selected and non-hybrid-selected
samples. The hybrid-selected clinical sample from Senegal (red)
clusters with 12 previously sequenced Senegal samples (blue). The
hybrid-selected 3D7 samples (red) cluster with the non-hybrid-
selected 3D7 sample (yellow). P. falciparum isolates from India
(purple) and Thailand (brown) are also represented. PC, principal
content.
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scale due to the gross excess of host DNA typically present.
The simplest way to compensate for host DNA contamina-
tion is to augment sequencing coverage depth. However,
this strategy can be costly for all but the most lightly con-
taminated samples. In contrast, the cost of purification by
hybrid selection using whole genome baits is approximately
US$250, which is roughly equivalent to the current cost of
generating 20-fold coverage of the 23 Mb P. falciparum
genome from pure template using a fraction of an Illumina
HiSeq lane. For augmented coverage to be an affordable
strategy relative to hybrid selection for a target coverage
level of 40 × in a genome of this size, samples must contain
at least 50% pathogen DNA. This titer of parasite DNA is
rarely found in clinical samples unless white cell depletion
is performed prior to DNA extraction. For a more typical
clinical sample containing only 1% P. falciparum DNA,
hybrid selection resulting in 40-fold enrichment enables 40
× coverage depth for a dramatically lower total price
(approximately $1,000) than deeper sequencing of the
unpurified sample (approximately $40,000).
Conclusions
T h em o d e s tc o s ta n dh i g hp e r f o r m a n c eo ft h i sh y b r i d
selection purification protocol will facilitate sequencing
of archival clinical samples of malaria parasites and other
pathogens previously considered unfit for sequencing by
any methodology. This may enable sequencing of impor-
tant samples stored on filter papers or diagnostic slides
predating the spread of drug resistance or associated with
historic outbreaks. This purification protocol also broad-
ens the accessibility of sequencing for clinical samples of
infectious organisms for which in vitro culture is possible
but costly or inconvenient, such as class IV ‘select agents’
recognized by the Centre for Disease Control. This pro-
tocol is not limited to pathogens, and should be equally
useful in sequencing commensal or symbiotic organisms
closely associated with their host, such as intracellular
Wolbachia bacteria, as was recently demonstrated by
Kent et al. in their application of an array-based capture
protocol [15]. The reduction in sample quality and quan-
tity requirements permitted by hybrid selection will sim-
plify protocol design in future large-scale clinical studies
and help realize the benefits of inexpensive, massively
parallel sequencing technologies for studying infectious
diseases in diverse contexts.
Materials and methods
Samples
Mock clinical samples were generated by mixing Homo
sapiens NA15510 DNA with a pure preparation of P.
falciparum 3D7 parasite DNA at a ratio of 99:1 (H.
sapiens: P. falciparum) by mass. Samples were fluores-
cently quantified prior to mixing using a PicoGreen [16]
assay. Authentic clinical samples were collected in 2008
from symptomatic patients at a clinic in Thies, Senegal
under an approved institutional review board protocol.
Samples consisted of whole blood dried and stored on a
Whatman FTA card (fast technology for analysis of
nucleic acids) and/or frozen whole blood stored in gly-
cerolyte 57 solution. DNA was extracted using a DNeasy
kit (Qiagen Hilden, North Rhine-Westphalia, Germany).
Whole frozen blood samples yielded sufficient DNA for
hybrid selection, but samples from FTA cards typically
yielded less than 100 ng of DNA and required WGA.
WGA was performed using the Repli-G kit (Qiagen).
Bait design and preparation
Synthetic 140-bp oligos were obtained from Agilent and
designed to capture exonic regions of the P. falciparum
genome as defined in the 3D7 v.5.0 reference assembly.
The final bait set included 24,246 oligos (3.4 Mb) with
unique BLAT matches to the P. falciparum 3D7 refer-
ence genome assembly and no homology to the human
genome. Baits and locations are listed in Additional file
2. To generate synthetic single-stranded biotinylated
RNA bait, in vitro transcription was performed with bio-
tin-labeled UTP using the MEGAshortscript T7 kit
(Ambion Austin, Texas, United States) as described pre-
viously [13].
WGB was generated at the Broad Institute. For input,
3 μgo fP. falciparum 3D7 DNA was sheared for 4 min-
utes on a Covaris E210 instrument set to duty cycle 5,
intensity 5 and 200 cycles per burst. The mode of the
resulting fragment size distribution was 250 bp. End
repair, addition of a 3’-A, adaptor ligation and reaction
clean-up followed the Illumina’s genomic DNA sample
preparation kit protocol except that adapter consisted of
oligonucleotides 5’-TGTAACATCACAGCATCACCGC
CATCAGTCxT-3’ (’x’ refers to an exonuclease I-resis-
tant phosphorothioate linkage) and 5’-[PHOS]GACTG
ATGGCGCACTACGACACTACAATGT-3’. The liga-
tion products were cleaned up (Qiagen), amplified by 8
to 12 cycles of PCR on an ABI GeneAmp 9700 thermo-
cycler in Phusion High-Fidelity PCR master mix with
HF buffer (NEB Ipswich, Massachusetts, United States)
using PCR forward primer 5’-CGCTCAGCGGCCG
CAGCATCACCGCCATCAGT-3’ and reverse primer 5’-
CGCTCAGCGGCCGCGTCGTAGTGCGCCATCAGT-
3’ (ABI Carlsbad, California, United States). Initial dena-
turation was 30 s at 98°C. Each cycle was 10 s at 98°C,
30 s at 50°C and 30 s at 68°C. PCR products were size-
selected on a 4% NuSieve 3:1 agarose gel followed by
QIAquick gel extraction. To add a T7 promoter, size-
selected PCR products were re-amplified as above using
the forward primer 5’-GGATTCTAATACGACTCAC
TATACGCTCAGCGGCCGCAGCATCACCGCCAT
CAGT-3’. Qiagen-purified PCR product was used as
Melnikov et al. Genome Biology 2011, 12:R73
http://genomebiology.com/2011/12/8/R73
Page 7 of 9template for whole genome biotinylated RNA bait pre-
paration with the MEGAshortscript T7 kit (Ambion)
[13].
Hybrid selection
Hybrid selection using either synthetic bait or WGB
was carried out as described previously [13]. Hybridi-
zation was conducted at 65°C for 66 h with 2 μgo f
‘pond’ libraries carrying standard or indexed Illumina
paired-end adapter sequences and 500 ng of bait in a
volume of 30 μl. After hybridization, captured DNA
was pulled down using streptavidin Dynabeads (Invi-
trogen Carlsbad, California, United States). Beads were
washed once at room temperature for 15 minutes with
0.5 ml 1 × SSC/0.1% SDS, followed by three 10-minute
washes at 65°C with 0.5 ml pre-warmed 0.1 × SSC/
0.1% SDS, re-suspending the beads once at each wash-
ing step. Hybrid-selected DNA was eluted with 50 μl
0.1 M NaOH. After 10 minutes at room temperature,
the beads were pulled down, the supernatant trans-
ferred to a tube containing 70 μlo f1MT r i s - H C l ,p H
7.5, and the neutralized DNA desalted and concen-
trated on a QIAquick MinElute column and eluted in
20 μl.
Quantitative PCR enrichment measurement
Enrichment of malaria DNA in samples was assessed
using a panel of malaria qPCR primers designed to con-
served regions of the P. falciparum 3D7 v.5.0 reference
genome. Enrichment for each amplicon was calculated
as the ratio between the amount of DNA presented pre-
and post-hybrid selection, with threshold cycle (cT)
counts corrected for qPCR efficiency using a standard
curve for each amplicon. All qPCR reactions utilized 1
μl of template containing 1 ng of total DNA. Estimated
enrichment for the samples was calculated as the mean
enrichment observed across all tested amplicons. Primer
sequences and locations are listed in Additional file 3.
Quantification of human DNA in the clinical samples
was performed prior to sequencing using the Taqman
RNase P Detection Reagents kit (Applied Biosystems
Carlsbad, California, United States).
Sequencing
Each sample was sequenced at the Broad Institute using
one lane of Illumina 76-bp paired-end reads. The
libraries of pure P. falciparum DNA and hybrid-selected
artificial clinical samples were each sequenced with one
Illumina GAIIx lane. The hybrid-selected authentic clin-
ical sample (Th231.08) was sequenced with one Illumina
HiSeq lane. Sequence data have been deposited in the
NCBI Short Read Archive under accession number
[SRA029706].
Analysis
Quality scores on Illumina reads were rescaled using the
MAQ sol2sanger utility [17]. Reads were then aligned to
P. falciparum 3D7 (PlasmoDB 5.0) using BWA [18].
Sequenced reads were sorted and the consensus
sequence was determined using the SAMtools utilities
[19]. %GC was calculated from 140-bp windows across
the P. falciparum genome.
The human:P. falciparum DNA ratio in each sequence
dataset was estimated from sequencing data by ran-
domly sampling 50K pairs of mated reads and measur-
ing the fractions that uniquely mapped to human versus
P. falciparum reference genome assemblies.
Simulated sequencing read coverage for the mock
clinical sample prior to hybrid selection was performed
by randomly sampling 1% of the read data generated for
the pure P. falciparum sample, under the tested
assumption that read coverage scales closely with para-
site DNA fraction.
Principal components analysis was performed using
Eigensoft software [20] on 8,300 non-singleton SNPs
with coverage of at least 10-fold in all strains and con-
sensus quality scores of at least 30.
Additional material
Additional file 1: Sequencing coverage comparison for 10-kb
genomic windows.
Additional file 2: Genomic locations of Agilent synthetic baits.
Additional file 3: P. falciparum qPCR primers and locations (3D7
v.5.0 assembly).
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nucleotide polymorphism; WGA: whole genome amplification; WGB: whole
genome bait.
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